Imunon (IMNN) Q2 2026 Earnings Call Transcript Phase 2 ovarian cancer data shows 45.1-month survival versus 30.4 months in control arm.
12 Health Care Stocks Moving In Tuesday's Pre-Market Session Gainers Jupiter Neurosciences (
NASDAQ:JUNS ) stock rose 36.4% to $0.23 during Tuesday's pre-market session. The market value of their outstanding shares is at $7.9 million. Imunon (
NASDAQ:IMNN ) shares moved upwards
IMUNON INC (NASDAQ:IMNN) Stock Soars 199% on Clinical Progress and Earnings Beat IMUNON stock surges 199% after beating Q3 earnings estimates and reporting strong progress in its Phase 3 ovarian cancer trial for IMNN-001.
IMUNON INC (NASDAQ:IMNN) Reports Mixed Q2 2025 Results with EPS Beat but Stock Decline IMUNON INC (
NASDAQ:IMNN ) reported Q2 2025 results, beating EPS estimates with a -$2.15 loss vs. -$4.83 expected. Despite progress in Phase 3 ovarian cancer trials, shares fell 5.4% pre-market amid biotech sector caution.
IMUNON (IMNN) Stock Is Trending Wednesday: What's Going On? Shares of IMUNON are trading higher Wednesday morning. The company announced a clinical milestone for its lead drug candidate, IMNN-001.
These stocks that are showing activity before the opening bell on Wednesday. Before the opening bell on Wednesday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session.
These stocks are gapping in today's session In today's session, there are notable price gaps in the US markets on Monday. Take a closer look at the stocks that are gap up and gap down.
Curious about the stocks that are showing activity after the closing bell on Thursday? Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements.
Top movers in Tuesday's after hours session Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements.
